Foundation Medicine, Horizon Health to Study Benefits of Precision Medicine in NSCLC | GenomeWeb

NEW YORK (GenomeWeb) – Foundation Medicine announced today that it has formed a three-way collaboration with Horizon Healthcare Services and Clinical Outcomes Tracking and Analysis (COTA) to study the clinical and cost benefits of Foundation's precision medicine technology in treating metastatic non-small cell lung cancer (NSCLC).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.